Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Neurol ; 61(6): 544-51, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17600364

RESUMO

OBJECTIVE: Glutamic acid decarboxylase (GAD) catalyzes the conversion of glutamic acid into GABA. GAD autoantibodies (GAD-Ab) have been described in diabetes mellitus and in diseases involving the central nervous system such as stiff-person syndrome and cerebellar ataxia. However, the pathogenic role of GAD-Ab in neurological diseases remains a matter of debate. METHODS: Using neurophysiological and neurochemical methods, we analyzed the effects of intracerebellar and paraspinal administration of GAD-Ab in rats. RESULTS: Intracerebellar administration of IgG from patients with GAD-Ab and neurological involvement (IgG-GAD) blocked the potentiation of the corticomotor response normally associated with trains of repetitive peripheral nerve stimulation. When injected in the lumbar paraspinal region, IgG-GAD induced continuous motor activity with repetitive discharges, abnormal exteroceptive reflexes, and increased excitability of anterior horn neurons, as assessed by F/M ratios. Furthermore, IgG-GAD significantly reduced the N-methyl-D-aspartate-mediated production of nitric oxide in cerebellar nuclei and impaired the synaptic regulation of glutamate after N-methyl-D-aspartate administration. These effects were not observed after administration of IgG from the following groups: (1) patients with GAD-Ab, diabetes mellitus, and without neurological complications; and (2) control patients. INTERPRETATION: These results indicate that stiff-person syndrome and cerebellar ataxia are the direct consequence of antibody-mediated neuronal dysfunction.


Assuntos
Autoanticorpos/farmacologia , Cerebelo/imunologia , Glutamato Descarboxilase/imunologia , Imunoglobulina G/farmacologia , Doenças do Sistema Nervoso/imunologia , Animais , Autoanticorpos/sangue , Autoanticorpos/isolamento & purificação , Cerebelo/efeitos dos fármacos , Cerebelo/metabolismo , Cromatografia de Afinidade , Vias de Administração de Medicamentos , Estimulação Elétrica , Potenciais Evocados/efeitos dos fármacos , Potenciais Evocados/imunologia , Agonistas de Aminoácidos Excitatórios/farmacologia , Ácido Glutâmico/metabolismo , Humanos , Imunoglobulina G/sangue , Imunoglobulina G/isolamento & purificação , Masculino , Microdiálise , Músculo Esquelético/inervação , N-Metilaspartato/farmacologia , Doenças do Sistema Nervoso/sangue , Óxido Nítrico/metabolismo , Ratos , Nervo Isquiático/efeitos dos fármacos , Medula Espinal/efeitos dos fármacos , Medula Espinal/fisiopatologia
2.
Genes Cells ; 11(12): 1337-52, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17121542

RESUMO

Collapsin response mediator proteins (CRMPs) consist of five homologous cytosolic proteins that participate in signal transduction involved in a variety of physiological events. CRMP1 is highly expressed during brain development; however, its functions remains unclear. To gain insight into its function, we generated CRMP1(-/-) mice with a knock-in LacZ gene. No gross anatomical changes or behavioral alterations were observed. Expression of CRMP1 was examined by the expression of the knocked-in LacZ gene, in situ hybridization with riboprobes and by imunohistochemistry. CRMP1 was found to be highly expressed in the developing the cerebellum, olfactory bulbs, hypothalamus and retina. In adults, expression level was high in the olfactory bulbs and hippocampus but very low in the retina and cerebellum and undetectable in hypothalamus. To study potential roles of CRMP1, we focused on cerebellum development. CRMP1(-/-) mice showed a decrease in the number of granule cells migrating out of explants of developing cerebellum, as did treatment of the explants from normal mice with anti-CRMP1 specific antibodies. CRMP1(-/-) mice showed a decrease in granule cell proliferation and apoptosis in external granule cell layers in vivo. Adult cerebellum of CRMP1(-/-) did not show any abnormalities.


Assuntos
Apoptose , Movimento Celular/fisiologia , Proliferação de Células , Cerebelo/crescimento & desenvolvimento , Grânulos Citoplasmáticos/fisiologia , Proteínas do Tecido Nervoso/genética , Animais , Bromodesoxiuridina/metabolismo , Células Cultivadas , Cerebelo/citologia , Técnica Indireta de Fluorescência para Anticorpo , Marcação de Genes , Genes Reporter , Imuno-Histoquímica , Hibridização In Situ , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas do Tecido Nervoso/deficiência , Proteínas do Tecido Nervoso/metabolismo , Técnicas de Cultura de Órgãos , Sondas RNA
3.
Eur J Neurosci ; 21(10): 2635-48, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15926912

RESUMO

Collapsin-response mediator proteins (CRMPs) are highly expressed in the developing brain where they take part in several aspects of neuronal differentiation. CRMPs are still present postnatally, but their function remains speculative in the adult brain. We studied the expression and localization of CRMP1, CRMP2 and CRMP5 in two areas of the nervous system with persistent neurogenesis in adult mice, the olfactory mucosa and the olfactory bulb. In the olfactory mucosa, we have established that CRMP expression is restricted to postmitotic cells of the olfactory neurons lineage. CRMP5 is coexpressed with growth associated protein of 43 kDa (GAP43) in immature olfactory neurons and is down-regulated in olfactory marker protein-positive mature neurons. In contrast, CRMP1 and CRMP2 persist at all stages of differentiation from immature GAP43-positive to fully mature olfactory neurons. In the olfactory bulb, CRMP1, CRMP2 and CRMP5 are abundant in neuronal progenitors of the subependymal layer and in differentiating interneurons. In both areas, the subcellular distribution of CRMP1 or CRMP2 is different in mature vs. immature neurons, suggesting that these proteins are sequentially involved in various cellular events during neuronal lifetime. The variations of CRMP expression following axotomy are consistent with their differential localization and functional involvement in immature vs. mature neurons of the olfactory system. Our data bring new insight to the putative functions of CRMPs within areas of the adult nervous system with permanent neurogenesis, some related to differentiation of newly generated neurons but others occurring in mature neurons with a limited lifespan.


Assuntos
Regulação da Expressão Gênica no Desenvolvimento , Proteínas do Tecido Nervoso/genética , Bulbo Olfatório/fisiologia , Sequência de Aminoácidos , Animais , Axotomia , Sequência de Bases , Primers do DNA , Imuno-Histoquímica , Peptídeos e Proteínas de Sinalização Intercelular , Interneurônios/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Dados de Sequência Molecular , Mucosa Olfatória/fisiologia , Nervo Olfatório/fisiologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa
4.
Mol Cell Neurosci ; 25(3): 433-43, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15033171

RESUMO

The pattern of sensory neuron extensions and connections is established during embryonic development through complex and varied guidance cues that control motility of growth cones and neurite morphogenesis. Semaphorins and neurotrophins are molecules that act as such cues. Collapsin response mediator proteins (CRMPs) are thought to be part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse. In this report, we present evidence that CRMPs are also involved in the neurite extension controlled by neurotrophins. We found that specific antibodies and the dominant-negative mutant protein for CRMP2 both potentiated the neurite extension induced by NGF, while specific antibodies and the corresponding mutant protein for CRMP1 both abolished the neurite extension induced by NT3. Our data suggest that CRMP2 has a negative effect on neurite extension induced by NGF and CRMP1 participates in the neurite formation/extension induced by NT3. These results point to a function for CRMPs in the regulation of neurite outgrowth induced by neurotrophins in sensory neurons.


Assuntos
Gânglios Espinais/fisiologia , Fatores de Crescimento Neural/farmacologia , Proteínas do Tecido Nervoso/fisiologia , Neuritos/fisiologia , Fosfoproteínas/fisiologia , Sequência de Aminoácidos , Animais , Embrião de Galinha , Relação Dose-Resposta a Droga , Gânglios Espinais/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização Intercelular , Camundongos , Dados de Sequência Molecular , Neuritos/efeitos dos fármacos
5.
Mol Neurobiol ; 28(1): 51-64, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-14514985

RESUMO

The members of the collapsin response mediator protein (CRMP) family-five cytosolic phosphoproteins -are highly expressed throughout brain development. The first member to be cloned, CRMP2, was identified as an intracellular messenger required for the growth cone-collapse induced by semaphorin 3A (Sema3A). A rapidly expanding body of study indicates that the functions of CRMPs are not solely limited to the signaling transduction of the Sema3A guidance cue. They are probably involved in multiple cellular and molecular events involved in apoptosis/proliferation, cell migration, and differentiation. In the adult brain, the expression of CRMPs is dramatically downregulated. However, they remain expressed in structures that retain their capacity for differentiation and plasticity and also in a subpopulation of oligodendrocytes (CRMP2 and CRMP5). Moreover, the expression of CRMPs is altered in neurodegenerative diseases, and these proteins may be of key importance in the physiopathology of the adult nervous system.


Assuntos
Envelhecimento/fisiologia , Proteínas Aviárias , Proteínas do Tecido Nervoso/fisiologia , Sistema Nervoso/crescimento & desenvolvimento , Sistema Nervoso/metabolismo , Doenças Neurodegenerativas/metabolismo , Semaforinas , Envelhecimento/metabolismo , Animais , Proteínas de Transporte/fisiologia , Humanos , Peptídeos e Proteínas de Sinalização Intercelular , Sistema Nervoso/citologia , Doenças Neurodegenerativas/patologia , Fosfoproteínas/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...